News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

15,385 Results

Type

Article (2265)
Company Profile (5)
Press Release (13115)

Section

Business (6245)
Career Advice (85)
Deals (911)
Drug Delivery (9)
Drug Development (2477)
Employer Resources (14)
FDA (416)
Job Trends (724)
News (9747)
Policy (838)

Tag

Date

Today (2)
Last 7 days (18)
Last 30 days (44)
Last 365 days (988)
2024 (692)
2023 (955)
2022 (1740)
2021 (1679)
2020 (1462)
2019 (1093)
2018 (846)
2017 (905)
2016 (623)
2015 (808)
2014 (519)
2013 (474)
2012 (446)
2011 (483)
2010 (404)

Filters

Type

Article (2265)
Company Profile (5)
Press Release (13115)

Section

Business (6245)
Career Advice (85)
Deals (911)
Drug Delivery (9)
Drug Development (2477)
Employer Resources (14)
FDA (416)
Job Trends (724)
News (9747)
Policy (838)

Tag

Date

Today (2)
Last 7 days (18)
Last 30 days (44)
Last 365 days (988)
2024 (692)
2023 (955)
2022 (1740)
2021 (1679)
2020 (1462)
2019 (1093)
2018 (846)
2017 (905)
2016 (623)
2015 (808)
2014 (519)
2013 (474)
2012 (446)
2011 (483)
2010 (404)

15,385 Results for "bristol myers squibb".

Sort By

Job Trends

European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab

Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated the extension application to introduce a new route of administration (subcutaneous use) for Opdivo®.

June 21, 2024
·
45 min read
Business

Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected independent director Michael R. McMullen to the Board, effective July 1, 2024.

June 18, 2024
·
3 min read
Deals

Bristol Myers Squibb Announces Dividend - June 18, 2024

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company.

June 18, 2024
·
1 min read
Business

Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb

Evotec SE announced that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb triggering a research payment of US$ 20 m to Evotec.

June 12, 2024
·
4 min read
Biotech Bay

Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb

Scenic Biotech announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.

April 30, 2024
·
2 min read
Biotech Bay

Bristol Myers Squibb to Participate in Upcoming Investor Conferences in May 2024

Bristol Myers Squibb announced that the company will participate in two upcoming investor conferences in May 2024.

May 7, 2024
·
1 min read
Pharm Country

Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference.

June 4, 2024
·
1 min read
Pharm Country

Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024

Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2024 on Friday, July 26, 2024. Company executives will review financial results and address inquiries from investors and analysts during a conference call beginning at 8:00 a.m. ET on the same date.

June 20, 2024
·
1 min read
Biotech Bay

Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb

Menten AI, Inc., a biotechnology company with a generative AI platform for design and optimization of peptide macrocycles, today announced the completion of a previously undisclosed research collaboration and licensing agreement with Bristol Myers Squibb applying Menten AI’s platform for optimization of cyclic peptides.

May 28, 2024
·
2 min read
Pharm Country

Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 28-31, 2024 in Miami, FL.

May 23, 2024
·
7 min read

1 of 1,539

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin